Cailian Wang Department of Oncology, School of Medicine Southeast University Biography Publications Institution JoVE Articles Cailian Wang has not added a biography. If you are Cailian Wang and would like to personalize this page please email our Author Liaison for assistance. Publications Evaluation of AMG510 Therapy on -Mutant Non-Small Cell Lung Cancer and Colorectal Cancer Cell Using a 3D Invasive Tumor Spheroid System Under Normoxia and Hypoxia Bioengineering (Basel, Switzerland). Dec, 2022 | Pubmed ID: 36550998 A Comprehensive Bioinformatic Analysis for Identification of Myeloid-Associated Differentiation Marker As a Potential Negative Prognostic Biomarker in Non-Small-Cell Lung Cancer Pathology Oncology Research : POR. 2022 | Pubmed ID: 36061144 Development and Validation of a DNA Methylation-related Classifier of Circulating Tumour Cells to Predict Prognosis and to Provide a Therapeutic Strategy in Lung Adenocarcinoma International Journal of Biological Sciences. 2022 | Pubmed ID: 35982906 High Expression of Is Associated with the Poor Prognosis and Immune Infiltration in Lung Adenocarcinoma Patients Disease Markers. 2022 | Pubmed ID: 35855850 Identification of Six Novel Prognostic Gene Signatures As Potential Biomarkers in Small Cell Lung Cancer Combinatorial Chemistry & High Throughput Screening. Apr, 2022 | Pubmed ID: 35490316 High-throughput and Label-free Enrichment of Malignant Tumor Cells and Clusters from Pleural and Peritoneal Effusions Using Inertial Microfluidics Lab on a Chip. May, 2022 | Pubmed ID: 35441644 Toripalimab Plus Chemotherapy in Treatment-naïve, Advanced Esophageal Squamous Cell Carcinoma (JUPITER-06): A Multi-center Phase 3 Trial Cancer Cell. 03, 2022 | Pubmed ID: 35245446 Low-cost Polymer-film Spiral Inertial Microfluidic Device for Label-free Separation of Malignant Tumor Cells Electrophoresis. Feb, 2022 | Pubmed ID: 34611912 Development and Validation of an E2F-Related Gene Signature to Predict Prognosis of Patients With Lung Squamous Cell Carcinoma Frontiers in Oncology. 2021 | Pubmed ID: 34745990 A Polymer-film Inertial Microfluidic Sorter Fabricated by Jigsaw Puzzle Method for Precise Size-based Cell Separation Analytica Chimica Acta. Jan, 2021 | Pubmed ID: 33384126 Recurrent Metastatic Penile Cancer Patient with Positive PD-L1 Expression Obtained Significant Benefit from Immunotherapy: A Case Report and Literature Review OncoTargets and Therapy. 2020 | Pubmed ID: 32368090 Inertial Microfluidic Cube for Automatic and Fast Extraction of White Blood Cells from Whole Blood Lab on a Chip. Jan, 2020 | Pubmed ID: 31833515 Immunomodulatory Effects of Chemotherapy on Blood Lymphocytes and Survival of Patients with Advanced Non-small Cell Lung Cancer International Journal of Immunopathology and Pharmacology. 2019 | Pubmed ID: 30968711 Targeted Microbubbles with Ultrasound Irradiation and PD-1 Inhibitor to Increase Antitumor Activity in B-cell Lymphoma Nanomedicine (London, England). Feb, 2018 | Pubmed ID: 29338562 LincRNAFEZF1-AS1 Represses P21 Expression to Promote Gastric Cancer Proliferation Through LSD1-Mediated H3K4me2 Demethylation Molecular Cancer. Feb, 2017 | Pubmed ID: 28209170 Intracellular PH-responsive and Rituximab-conjugated Mesoporous Silica Nanoparticles for Targeted Drug Delivery to Lymphoma B Cells Journal of Experimental & Clinical Cancer Research : CR. Feb, 2017 | Pubmed ID: 28166836 A Microemulsion Co-loaded with Schizandrin A-docetaxel Enhances Esophageal Carcinoma Treatment Through Overcoming Multidrug Resistance Drug Delivery. Nov, 2017 | Pubmed ID: 28155336 Rituximab-conjugated, Doxorubicin-loaded Microbubbles As a Theranostic Modality in B-cell Lymphoma Oncotarget. Jan, 2017 | Pubmed ID: 27902473 ETS-1: A Potential Target of Glycolysis for Metabolic Therapy by Regulating Glucose Metabolism in Pancreatic Cancer International Journal of Oncology. Jan, 2017 | Pubmed ID: 27878249 Trends and Advances in Tumor Immunology and Lung Cancer Immunotherapy Journal of Experimental & Clinical Cancer Research : CR. Sep, 2016 | Pubmed ID: 27686848 Rituximab-conjugated and Doxorubicin-loaded Microbubbles Combined with Ultrasound Irradiation Inhibits Proliferation and Induces Apoptosis in Raji Cell Lines Oncology Reports. Feb, 2016 | Pubmed ID: 26718487 Is the Autophagy a Friend or Foe in the Silver Nanoparticles Associated Radiotherapy for Glioma? Biomaterials. Sep, 2015 | Pubmed ID: 26022979 Transcriptional Silencing of ETS-1 Abrogates Epithelial-mesenchymal Transition Resulting in Reduced Motility of Pancreatic Cancer Cells Oncology Reports. Feb, 2015 | Pubmed ID: 25421630 Silver Nanoparticles: a Novel Radiation Sensitizer for Glioma? Nanoscale. Dec, 2013 | Pubmed ID: 24126539 The Real-time Neurotoxicity Analysis of Fe3O4 Nanoparticles Combined with Daunorubicin for Rat Brain in Vivo Journal of Biomedical Nanotechnology. Jun, 2012 | Pubmed ID: 22764410 Gambogic Acid-loaded Magnetic Fe(3)O(4) Nanoparticles Inhibit Panc-1 Pancreatic Cancer Cell Proliferation and Migration by Inactivating Transcription Factor ETS1 International Journal of Nanomedicine. 2012 | Pubmed ID: 22393285 Daunorubicin-TiO2 Nanocomposites As a "smart" PH-responsive Drug Delivery System International Journal of Nanomedicine. 2012 | Pubmed ID: 22275838 Study of the Enhanced Anticancer Efficacy of Gambogic Acid on Capan-1 Pancreatic Cancer Cells when Mediated Via Magnetic Fe3O4 Nanoparticles International Journal of Nanomedicine. 2011 | Pubmed ID: 21931488 A Strategy for ZnO Nanorod Mediated Multi-mode Cancer Treatment Biomaterials. Mar, 2011 | Pubmed ID: 21145104 Geração de esferoides tumorais 3D para estudos de avaliação de fármacos Wei Hou*1,2, Zilin Zhang*3,4, Jing Zhang3,4, Shihui Xu2,4, Menglan Li4, Xiaoran Li2,4, Zaozao Chen2,3, Cailian Wang1,2 1Department of Oncology, School of Medicine, Southeast University, 2State Key Laboratory of Bioelectronics, School of Biological Science and Medical Engineering, Southeast University, 3Institute of Medical Devices (Suzhou), Southeast University, 4Jiangsu Avatarget Biotechnology Co., Ltd. JoVE 65125 Cancer Research
Geração de esferoides tumorais 3D para estudos de avaliação de fármacos Wei Hou*1,2, Zilin Zhang*3,4, Jing Zhang3,4, Shihui Xu2,4, Menglan Li4, Xiaoran Li2,4, Zaozao Chen2,3, Cailian Wang1,2 1Department of Oncology, School of Medicine, Southeast University, 2State Key Laboratory of Bioelectronics, School of Biological Science and Medical Engineering, Southeast University, 3Institute of Medical Devices (Suzhou), Southeast University, 4Jiangsu Avatarget Biotechnology Co., Ltd. JoVE 65125 Cancer Research
